Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
New forms of treatment and PrEP and, hopefully, an at least partially effective vaccine will be key to fighting the epidemic in the 2020s.
Researchers conducted a systematic review of 60 studies in search of answers.
The implant is infused with a drug meant to keep the immune cells that the virus targets in a resting state.
An analysis of a previous study of a tenofovir-based vaginal gel found that women with vaginal inflammation were less protected.
A one-month version of the ring is currently up for regulatory approval.
Courting controversy, the NIH considers a shift away from the development of new vaginal or rectal-based HIV prevention products.
Here’s how you can take action to support rectal microbicide research.
An anti-HIV vaginal microbicide gel lowered risk among women with a healthier dominant bacterial population.
Researchers have made progress in developing a microbicide enema that protects against contracting HIV through anal sex.
Scientists have made progress developing such a microbicide, with promising results in tests among monkeys.
All of the big HIV science revelations from the Conference on Retroviruses and Opportunistic Infections, including the PrEP failure case.
A trial of a Viread (tenofovir)-containing vaginal gel to protect against HIV has failed because the South African women participants used it...
The NIH has awarded a $14.7 million grant to a team developing a microbicide with an HIV-fighting protein they will cultivate in tobacco plant...
An Isentress-containing microbicide gel prevents vaginal transmission of the simian cousin of HIV, SIV, when used as a post-exposure...
After many years of failures, recent studies have moved researchers closer to a form of HIV prevention that women can use discreetly.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.